NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing novel approaches for the global eye care market including revolutionary natural non-antibiotic antimicrobial products, today announced that the New York Stock Exchange has accepted NovaBay's plan to regain compliance with the NYSE MKT's continued listing standards. As previously disclosed, the NYSE notified the Company on April 28, 2015 that it had fall
